Zim Laboratories

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE518E01015
  • NSEID: ZIMLAB
  • BSEID: 541400
INR
79.01
-0.53 (-0.67%)
BSENSE

Jan 19

BSE+NSE Vol: 69.97 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Medico Remedies
Trident Lifeline
Haleos Labs Limi
Amanta Healthcar
Valiant Laborato
Zim Laboratories
Albert David
Nectar Lifesci.
Kerala Ayurveda
Influx Health.
Infinium Pharma

Why is Zim Laboratories Ltd ?

1
Weak Long Term Fundamental Strength with a -6.74% CAGR growth in Operating Profits over the last 5 years
  • The company has been able to generate a Return on Equity (avg) of 6.55% signifying low profitability per unit of shareholders funds
2
The company has declared Negative results for the last 6 consecutive quarters
  • PBT LESS OI(Q) At Rs -2.38 cr has Fallen at -245.12%
  • PAT(Q) At Rs -0.42 cr has Fallen at -117.6%
  • ROCE(HY) Lowest at 6.21%
3
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 7.53% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -25.92% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Zim Laboratories for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Zim Laboratories
-25.32%
-0.51
49.34%
Sensex
8.65%
0.76
11.31%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
3.96%
EBIT Growth (5y)
-6.74%
EBIT to Interest (avg)
3.11
Debt to EBITDA (avg)
2.09
Net Debt to Equity (avg)
0.48
Sales to Capital Employed (avg)
1.24
Tax Ratio
40.22%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.22%
ROCE (avg)
9.05%
ROE (avg)
6.55%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
58
Industry P/E
33
Price to Book Value
1.52
EV to EBIT
31.08
EV to EBITDA
13.88
EV to Capital Employed
1.35
EV to Sales
1.37
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
4.35%
ROE (Latest)
2.62%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-15What is not working for the Company
PBT LESS OI(Q)

At Rs -2.38 cr has Fallen at -245.12%

PAT(Q)

At Rs -0.42 cr has Fallen at -117.6%

ROCE(HY)

Lowest at 6.21%

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 1.45 cr

DEBT-EQUITY RATIO(HY)

Highest at 0.48 times

Loading Valuation Snapshot...

Here's what is not working for Zim Laboratories

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -2.38 cr has Fallen at -245.12%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs -0.42 cr has Fallen at -117.6%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Cash and Cash Equivalents - Half Yearly
Lowest at Rs 1.45 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio - Half Yearly
Highest at 0.48 times
in the last five half yearly periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Non Operating Income - Quarterly
Highest at Rs 2.04 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income